Cargando…
The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319923/ https://www.ncbi.nlm.nih.gov/pubmed/32788116 http://dx.doi.org/10.1016/j.thromres.2020.06.042 |
| _version_ | 1783551139521757184 |
|---|---|
| author | Previtali, Giulia Seghezzi, Michela Moioli, Valentina Sonzogni, Aurelio Cerutti, Lorenzo Marozzi, Roberto Ravasio, Rudi Gianatti, Andrea Guerra, Giovanni Alessio, Maria Grazia |
| author_facet | Previtali, Giulia Seghezzi, Michela Moioli, Valentina Sonzogni, Aurelio Cerutti, Lorenzo Marozzi, Roberto Ravasio, Rudi Gianatti, Andrea Guerra, Giovanni Alessio, Maria Grazia |
| author_sort | Previtali, Giulia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7319923 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73199232020-06-29 The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome? Previtali, Giulia Seghezzi, Michela Moioli, Valentina Sonzogni, Aurelio Cerutti, Lorenzo Marozzi, Roberto Ravasio, Rudi Gianatti, Andrea Guerra, Giovanni Alessio, Maria Grazia Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2020-10 2020-06-27 /pmc/articles/PMC7319923/ /pubmed/32788116 http://dx.doi.org/10.1016/j.thromres.2020.06.042 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editors-in-Chief Previtali, Giulia Seghezzi, Michela Moioli, Valentina Sonzogni, Aurelio Cerutti, Lorenzo Marozzi, Roberto Ravasio, Rudi Gianatti, Andrea Guerra, Giovanni Alessio, Maria Grazia The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome? |
| title | The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome? |
| title_full | The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome? |
| title_fullStr | The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome? |
| title_full_unstemmed | The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome? |
| title_short | The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome? |
| title_sort | pathogenesis of thromboembolic disease in covid-19 patients: could be a catastrophic antiphospholipid syndrome? |
| topic | Letter to the Editors-in-Chief |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319923/ https://www.ncbi.nlm.nih.gov/pubmed/32788116 http://dx.doi.org/10.1016/j.thromres.2020.06.042 |
| work_keys_str_mv | AT previtaligiulia thepathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT seghezzimichela thepathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT moiolivalentina thepathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT sonzogniaurelio thepathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT ceruttilorenzo thepathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT marozziroberto thepathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT ravasiorudi thepathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT gianattiandrea thepathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT guerragiovanni thepathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT alessiomariagrazia thepathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT previtaligiulia pathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT seghezzimichela pathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT moiolivalentina pathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT sonzogniaurelio pathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT ceruttilorenzo pathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT marozziroberto pathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT ravasiorudi pathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT gianattiandrea pathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT guerragiovanni pathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome AT alessiomariagrazia pathogenesisofthromboembolicdiseaseincovid19patientscouldbeacatastrophicantiphospholipidsyndrome |